Director exercises 7,500 stock appreciation rights at Wilson Bank Holding Co (WBHC)
Rhea-AI Filing Summary
RICHERSON HERBERT ELMER reported disposition transactions in this Form 4 filing.
Wilson Bank Holding Co director Herbert Elmer Richerson exercised 7,500 Stock Appreciation Rights on July 20, 2026. These cash-settled rights were tied to 7,500 shares of common stock with a $40.25 exercise price and had fully vested by September 26, 2021. Following this exercise, all rights from this award have been fully settled, leaving no remaining derivative balance under this grant.
Positive
- None.
Negative
- None.
Insider Trade Summary
7,500 shares exercised/converted
Exercise
1 txn
Insider
RICHERSON HERBERT ELMER
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Stock Appreciation Rights F1 | 7,500 | $0.00 | $0.00 |
Holdings After Transaction:
Stock Appreciation Rights — 0 shares (Direct)
Footnotes (1)
- F1. This cash-settled stock appreciation right fully vested on 9/26/2021. All shares have been exercised.
Key Figures
Stock Appreciation Rights Exercised: 7,500 rights
Exercise Price: $40.25 per share
Transaction Date: July 20, 2026
+2 more
5 metrics
Stock Appreciation Rights Exercised
7,500 rights
Number of Stock Appreciation Rights exercised on July 20, 2026
Exercise Price
$40.25 per share
Exercise price of the Stock Appreciation Rights linked to common stock
Transaction Date
July 20, 2026
Date the exercise of Stock Appreciation Rights was reported
Underlying Shares
7,500 shares
Shares of common stock referenced by the exercised Stock Appreciation Rights
Derivative Balance After Exercise
0 rights
Stock Appreciation Rights remaining from this award after the reported exercise
Key Terms
Stock Appreciation Rights, cash-settled stock appreciation right, derivative security, underlying security
4 terms
Stock Appreciation Rights financial
"security_title: Stock Appreciation Rights"
Stock appreciation rights (SARs) are a form of employee compensation that give the holder the right to receive the increase in a company's stock price over a set baseline, paid in cash or shares, without having to buy the stock. For investors, SARs matter because they can create future cash outflows or share dilution and signal how a company rewards and motivates executives — similar to giving a bonus tied directly to how well the company’s stock performs.
cash-settled stock appreciation right financial
"This cash-settled stock appreciation right fully vested on 9/26/2021."
derivative security financial
"transaction_code_description: Exercise or conversion of derivative security"
A derivative security is a financial contract whose value comes from the price or performance of something else, such as a stock, bond, commodity, or market index. For investors it acts like an insurance policy or a wager: it can be used to protect against losses, lock in prices, or amplify gains and losses, so it can change a portfolio’s risk and potential return without owning the underlying asset directly.
underlying security financial
"underlying_security_title: Common Stock"
AI-generated analysis. How Rhea-AI works. Not financial advice.
FAQ
What insider transaction did WBHC director Herbert Elmer Richerson report?
Herbert Elmer Richerson reported exercising 7,500 Stock Appreciation Rights on July 20, 2026. These cash-settled rights were linked to WBHC common stock at a $40.25 exercise price, and this exercise fully settled that specific award.
How many stock appreciation rights were exercised in this WBHC Form 4?
The Form 4 reports the exercise of 7,500 Stock Appreciation Rights. Each right was tied to one share of WBHC common stock, so the award referenced 7,500 underlying shares that determined the cash value of the exercise.
What was the exercise price of the stock appreciation rights in the WBHC filing?
The stock appreciation rights carried an exercise price of $40.25 per share. This price represents the base value used to calculate the cash benefit of the rights linked to WBHC common stock when they were exercised.
When did the exercised WBHC stock appreciation rights fully vest?
The cash-settled stock appreciation right fully vested on September 26, 2021. Although it became fully exercisable on that date, the reporting director completed the exercise of the remaining 7,500 rights on July 20, 2026.
Are any stock appreciation rights from this WBHC award still outstanding after the transaction?
No. The Form 4 indicates that all shares have been exercised under this award, and the position in these Stock Appreciation Rights is now 0, meaning nothing from this specific derivative grant remains outstanding.
Was the WBHC insider transaction reported under a Rule 10b5-1 trading plan?
The Rule 10b5-1 checkbox for this Form 4 is not marked as affirming a trading plan. The report therefore does not classify this particular exercise of Stock Appreciation Rights as executed under a disclosed Rule 10b5-1 plan.